Related references
Note: Only part of the references are listed.Capecitabine: have we got the dose right?
Rachel Midgley et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
B. Glimelius et al.
ANNALS OF ONCOLOGY (2008)
A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer
R Sharma et al.
BRITISH JOURNAL OF CANCER (2006)
Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: A population-based analysis
Cheryl Ho et al.
CLINICAL COLORECTAL CANCER (2005)
Folate, DNA stability and colo-rectal neoplasia
SJ Duthie et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2004)
Capecitabine: Fixed daily dose and continuous (noncyclic) dosing schedule
J Lokich
CANCER INVESTIGATION (2004)
Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer
B Glimelius et al.
ANNALS OF ONCOLOGY (2002)
Folate status and the safety profile of antifolates
H Calvert
SEMINARS IN ONCOLOGY (2002)
Relevance of folate metabolism in the pathogenesis of colorectal cancer
BM Ryan et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Beneficial role for folate in the prevention of colorectal and breast cancer
R Prinz-Langenohl et al.
EUROPEAN JOURNAL OF NUTRITION (2001)
Serum cobalamin, folate, methylmalonic acid and total homocysteine as vitamin B12 and folate tissue deficiency markers amongst elderly Swedes -: a population-based study
K Björkegren et al.
JOURNAL OF INTERNAL MEDICINE (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
